Individual Plasmodium vivax msp1 Variants within Polyclonal P. vivax Infections Display Different Propensities for Relapse

ABSTRACT Using a newly developed Plasmodium vivax merozoite surface protein 1 gene (Pvmsp1) heteroduplex tracking assay, we genotyped 107 P. vivax infections in individuals from Cambodia, 45 of whom developed recurrent parasitemia within 42 days. The majority of isolates were polyclonal, but recurrent parasitemias displayed fewer variants compared to initial parasitemias. Two Pvmsp1 gene variants occurred more frequently in the initial genotypes of those who developed recurrent parasitemia, representing the first time P. vivax variants associated with a higher risk of relapse have been described.

[1]  W. Rojas,et al.  High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia , 2011, Acta Tropica.

[2]  S. Meshnick,et al.  Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment , 2011, PloS one.

[3]  R. Price,et al.  Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Organización Mundial de la Salud.  Guidelines for the treatment of malaria , 2010 .

[5]  C. Wongsrichanalai,et al.  Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia , 2009, Malaria Journal.

[6]  D. Hartl,et al.  Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. , 2008, Gene.

[7]  M. Gatton,et al.  Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. , 2007, The Journal of infectious diseases.

[8]  J. Carlton,et al.  Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. , 2007, The Journal of infectious diseases.

[9]  S. Meshnick,et al.  Estimating True Antimalarial Efficacy by Heteroduplex Tracking Assay in Patients with Complex Plasmodium falciparum Infections , 2006, Antimicrobial Agents and Chemotherapy.

[10]  S. Meshnick,et al.  Measuring allelic heterogeneity in Plasmodium falciparum by a heteroduplex tracking assay. , 2005, The American journal of tropical medicine and hygiene.

[11]  N. White,et al.  Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. , 2004, Acta tropica.

[12]  Virander S. Chauhan,et al.  Inter-allelic recombination in the Plasmodium vivax merozoite surface protein 1 gene among Indian and Colombian isolates , 2004, Malaria Journal.

[13]  Guofa Zhou,et al.  Genetic diversity and multiple infections of Plasmodium vivax malaria in Western Thailand. , 2003, The American journal of tropical medicine and hygiene.

[14]  C. C. Campbell,et al.  In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells. , 1986, The American journal of tropical medicine and hygiene.

[15]  P. Garnham,et al.  The life-cycle of primate malaria parasites. , 1982, British medical bulletin.